Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Bettermann Kira |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2020

Korrektur

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268].
Transl Oncol. 2020; 13(2):490-492 Doi: 10.1016/j.tranon.2019.08.001 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268 Doi: 10.1016/j.tranon.2018.10.010 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Bettermann, K; Mehta, AK; Hofer, EM; Wohlrab, C; Golob-Schwarzl, N; Svendova, V; Schimek, MG; Stumptner, C; Thüringer, A; Speicher, MR; Lackner, C; Zatloukal, K; Denk, H; Haybaeck, J Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis.
Oncotarget. 2016; 7(45):73309-73322 Doi: 10.18632/oncotarget.12325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Abstract (Zeitschrift)

** Lederer, E; Petzold, J; Rehis, R; Ernst, C; Bettermann, K; Golob-Schwarzl, N; Moriggl, R; Schlederer, M; Lax, S; Hoffmann, J; Haybaek, J The role of the JAK/STAT pathway in gallbladder cancer
VIRCHOWS ARCH. 2015; 467: S3-S3. [Oral Communication]
Web of Science

 

2014

Übersichtsarbeit

** Bettermann, K; Hohensee, T; Haybaeck, J Steatosis and steatohepatitis: complex disorders.
Int J Mol Sci. 2014; 15(6):9924-9944 Doi: 10.3390/ijms15069924 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Ress, AL; Bettermann, K; Schauer, S; Koller, K; Eisner, F; Kiesslich, T; Stojakovic, T; Samonigg, H; Kornprat, P; Lackner, C; Haybaeck, J; Pichler, M Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
Br J Cancer. 2013; 108(9):1830-1837 Doi: 10.1038/bjc.2013.165 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bettermann, K; Mehta, AK; Lederer, E; Ernst, C; Kessler, SM; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, BC; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Mahajan, V; Stumptner, C; Thueringer, A; Stojakovic, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Lackner, C; Haybäck, J Steatohepatitis-associated Hepatocellular Carcinoma: Evidence of a Keratinopathy.
HEPATOLOGY. 2013; 58(S1):543A-543A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA. [Poster]
Web of Science

 

2012

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Haybaeck, J; Schauer, S; Kiesslich, T; Bettermann, K; Griessbacher, A; Stojakovic, T; Bauernhofer, T; Samonigg, H; Kornprat, P; Lackner, C; Pichler, M NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Hum Pathol. 2012; 43(7):1012-1019 Doi: 10.1016/j.humpath.2011.08.009
Web of Science PubMed FullText FullText_MUG

 

** Haybaeck, J; Llenos, IC; Dulay, RJ; Bettermann, K; Miller, CL; Wälchli, T; Frei, K; Virgintino, D; Rizzi, M; Weis, S Expression of nogo-a is decreased with increasing gestational age in the human fetal brain.
Dev Neurosci. 2012; 34(5):402-416 Doi: 10.1159/000343143 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, E; Zöhrer, E; Bettermann, K; Haybaeck, J Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?
Hepat Mon. 2012; 12(10 HCC):e7879-e7879 Doi: 10.5812/hepatmon.7879 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Bettermann, K; Benesch, M; Weis, S; Haybaeck, J SUMOylation in carcinogenesis.
Cancer Lett. 2012; 316(2):113-125 Doi: 10.1016/j.canlet.2011.10.036
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bettermann, K; Mehta, AK; Lederer, E; Diwoky, C; Thuringer, A; Muller, H; Mahajan, VS; Stumptner, C; Kolbe, T; Magin, TM; Denk, H; Lackner, C; Zatloukal, K; Haybaeck, J; Steatohepatitis-driven hepatocellular carcinoma.
INT J MOL MED. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE30: S6-S6. ATHENS: SPANDIDOS PUBL LTD; [Oral Communication]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Roderburg, C; Urban, GW; Bettermann, K; Vucur, M; Zimmermann, H; Schmidt, S; Janssen, J; Koppe, C; Knolle, P; Castoldi, M; Tacke, F; Trautwein, C; Luedde, T Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
Hepatology. 2011; 53(1):209-218 Doi: 10.1002/hep.23922 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Originalarbeit (Zeitschrift)

** Bettermann, K; Vucur, M; Haybaeck, J; Koppe, C; Janssen, J; Heymann, F; Weber, A; Weiskirchen, R; Liedtke, C; Gassler, N; Müller, M; de Vos, R; Wolf, MJ; Boege, Y; Seleznik, GM; Zeller, N; Erny, D; Fuchs, T; Zoller, S; Cairo, S; Buendia, MA; Prinz, M; Akira, S; Tacke, F; Heikenwalder, M; Trautwein, C; Luedde, T TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.
Cancer Cell. 2010; 17(5):481-496 Doi: 10.1016/j.ccr.2010.03.021 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Vucur, M; Roderburg, C; Bettermann, K; Tacke, F; Heikenwalder, M; Trautwein, C; Luedde, T Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?
Oncotarget. 2010; 1(5):373-378 Doi: 10.18632/oncotarget.170 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

© Med Uni Graz Impressum